Identification of S6K2 as a centrosome-located kinase

Area of Science:

• Cell Biology
• Molecular Biology
• Signal Transduction

Background:

• Ribosomal S6 kinase 2 (S6K2) is a key downstream effector of the mammalian target of rapamycin (mTOR) signaling pathway.
• The PI3K/Akt/mTOR pathway regulates fundamental cellular processes, including growth, proliferation, and survival.
• While S6K1 is well-characterized, the specific functions and localization of S6K2 are less understood.

Purpose of the Study:

• To investigate the subcellular localization of Ribosomal S6 kinase 2 (S6K2).
• To determine if S6K2 localization is regulated by cellular conditions or specific signaling inhibitors.
• To compare the centrosomal localization of S6K2 with its paralog, S6K1, and explore potential functional implications.

Main Methods:

• Immunofluorescence microscopy to visualize S6K2 localization within cells.
• Cell treatments including serum withdrawal and inhibitors of key signaling pathways (rapamycin, wortmannin, U0126, PMA).
• Comparative analysis of S6K2 and S6K1 localization.

Main Results:

• S6K2 was found to localize to the centrosome, specifically in the pericentriolar area, throughout the cell cycle.
• Centrosomal localization of S6K2 remained unaffected by serum withdrawal or treatment with rapamycin, wortmannin, U0126, or PMA.
• S6 kinase 1 (S6K1) did not exhibit centrosomal localization, highlighting a difference between the two kinases.

Conclusions:

• Centrosomal localization of S6K2 suggests a potential role in centrosome function or regulation.
• The distinct localization of S6K2 compared to S6K1 implies non-overlapping functions for these related kinases.
• Centrosomal S6K2 may participate in the PI3K/Akt/mTOR signaling pathway, which has also been observed at the centrosome.